In the present study, our analysis has shown that CD276 expression was positively correlated with a number of immune checkpoint genes, including TGFBR1, TGFB1, NECTIN2, IL10RB and CSF1R, in most types of cancer. This evidence concerns the gene CD276 and cancer.